Blajchman M A, Senyi A F, Hirsh J, Genton E, George J N
J Clin Invest. 1981 Nov;68(5):1289-94. doi: 10.1172/jci110375.
Although in vitro studies have demonstrated functional differences between young and old platelets, in vivo differences have not been precisely established. Therefore the in vivo hemostatic function of young and old platelets and the survival time have been examined in rabbits. The hemostatic function was measured by performing serial ear bleeding times in irradiation-induced thrombocytopenic rabbits. After irradiation with 930 rad the platelet count gradually diminished reaching a nadir ( approximately 20 x 10(3)/mul) at 10 d. The platelets present in the circulation, 7-10 d after irradiation, were considered old platelets, and the platelets present after recovery, 11-14 d postirradiation, young platelets. The measurement of platelet size was consistent with the hypothesis that platelets become smaller with age: the mean size was 3.84 mum(3) for old platelets and 5.86 mum(3) for young platelets. Regression analysis of the relationship between the bleeding time and the platelet count in 18 rabbits showed a significantly different slope for rabbits with predominantly old platelets compared with rabbits with predominantly young platelets (P < 0.001). Young platelets were more effective giving much shorter bleeding times than old platelets at comparable platelet counts. Survival times of young and old platelets were measured using platelets harvested on day 8 postirradiation (old platelets) and day 12 postirradiation (young platelets) that were labeled and then reinjected into normal recipient animals. The mean platelet survival time, calculated by gamma function, of old platelets was 28.8 h; of young platelets, 87.4 h; and of normally circulating heterogeneous platelets, (normal platelets) 53.0 h. Notably, the survival of old platelets was found to be exponential, and of young platelets, linear. Analysis of the membrane glycoproteins in young, old and normal platelets indicated that there was no qualitative difference amongst the young, normal, and old platelets. The relative relationship among all the glycoprotein peaks was equal and the only changes observed were quantitative, with young platelets having significantly more membrane glycoprotein per cell than old platelets and normal platelets. Normal platelets had intermediate concentrations of each glycoprotein. These results demonstrate that young platelets are hemostatically more effective in vivo than old platelets. The data are compatible with the hypothesis that platelets age in the circulation by losing membrane fragments and then after becoming senescent, are removed from the circulation by a random process.
尽管体外研究已证实年轻血小板与衰老血小板之间存在功能差异,但体内差异尚未得到确切证实。因此,研究人员在兔子身上检测了年轻血小板与衰老血小板的体内止血功能以及存活时间。通过对辐照诱导的血小板减少症兔子进行连续耳出血时间测定来衡量止血功能。经930拉德辐照后,血小板计数逐渐减少,在第10天达到最低点(约20×10³/微升)。辐照后7 - 10天循环中的血小板被视为衰老血小板,辐照后11 - 14天恢复后的血小板被视为年轻血小板。血小板大小的测量结果与血小板随年龄增长而变小的假设一致:衰老血小板的平均大小为3.84立方微米,年轻血小板为5.86立方微米。对18只兔子的出血时间与血小板计数之间关系的回归分析表明,与主要为年轻血小板的兔子相比,主要为衰老血小板的兔子的斜率有显著差异(P < 0.001)。在血小板计数相当的情况下,年轻血小板比衰老血小板更有效,出血时间短得多。使用辐照后第8天采集的血小板(衰老血小板)和辐照后第12天采集的血小板(年轻血小板)进行标记,然后重新注入正常受体动物体内,来测量年轻血小板与衰老血小板的存活时间。通过伽马函数计算,衰老血小板的平均存活时间为28.8小时;年轻血小板为87.4小时;正常循环的异质性血小板(正常血小板)为53.0小时。值得注意的是,衰老血小板的存活呈指数形式,而年轻血小板呈线性。对年轻、衰老和正常血小板的膜糖蛋白分析表明,年轻、正常和衰老血小板之间在质量上没有差异。所有糖蛋白峰之间的相对关系是相等的,观察到的唯一变化是数量上的,年轻血小板每细胞的膜糖蛋白明显多于衰老血小板和正常血小板。正常血小板的每种糖蛋白浓度处于中间水平。这些结果表明,年轻血小板在体内的止血效果比衰老血小板更有效。这些数据与以下假设相符:血小板在循环中通过失去膜碎片而老化,然后在衰老后通过随机过程从循环中清除。